Literature DB >> 21762999

Delusional infestation: treatment outcome with antipsychotics in 17 consecutive patients (using standardized reporting criteria).

Markus Huber1, Peter Lepping, Roger Pycha, Martin Karner, Josef Schwitzer, Roland W Freudenmann.   

Abstract

OBJECTIVE: The multietiological nature of delusional infestation (DI) implies that therapy needs to be customized according to the various forms of DI (primary/secondary). Usually, treatment of DI is difficult to achieve in psychiatric settings because of the patients' nonpsychiatric concept of the illness.
METHODS: We analyzed the data of all consecutive DI patients seen in the Psychiatric Outpatient Department of the General Hospital Bruneck/Italy from 1998 to 2010, including structural brain imaging findings. Standardized reporting criteria are applied for the presentation of the cases in a naturalistic setting.
RESULTS: Our sample consisted of 17 patients. Notably, 15 out of these 17 patients (88%) could be engaged in an antipsychotic treatment trial. With different, mainly second-generation antipsychotics, all but one patient profited from antipsychotics, at least after substances were changed: 12 (71%) of the cases reached full remission, and another 2 (12%) had partial remission. The average duration of treatment was remarkably long: 3.8 years. Eight cases were classified as secondary to a brain disorder or medical condition, four cases were classified as secondary to psychiatric disorders and five cases fulfilled the criteria for primary DI (i.e., delusional disorder somatic type). All cases secondary to a brain disorder/medical condition showed macroscopic brain lesions mainly in the basal ganglia.
CONCLUSIONS: Our study confirmed previous experience that an excellent clinical outcome can be achieved in unselected patients with different DI forms provided that patients can be engaged in antipsychotic treatment. Although studies in DI are difficult to conduct, randomized controlled trials would be desirable to evaluate specific antipsychotic medication in DI in general and in the different forms of DI. More sophisticated investigations (single photon emission computed tomography and positron emission tomography) than structural brain imaging (magnetic resonance imaging and computed tomography) are needed to better elucidate underlying brain dysfunction in DI. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762999     DOI: 10.1016/j.genhosppsych.2011.05.013

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  6 in total

1.  Delusional Infestation Can Be a Complication of Prurigo Nodularis with Underlying Neuropathies.

Authors:  Charles Dervout; Florian Stephan; Laurent Misery
Journal:  Acta Derm Venereol       Date:  2020-07-28       Impact factor: 3.875

2.  Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report.

Authors:  Laura Ponson; Frédéric Andersson; Wissam El-Hage
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-02       Impact factor: 2.570

Review 3.  Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines.

Authors:  Cody J Connor
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-20

4.  Delusional Infestation Secondary to the Dopamine Agonist Ropirinole in a Patient With Parkinson's Disease: A Case Report With an Outline of the Biology of Psychosis.

Authors:  Hassan Kesserwani
Journal:  Cureus       Date:  2021-01-23

5.  Successful ziprasidone monotherapy in a case of delusional parasitosis: a one-year followup.

Authors:  Domenico De Berardis; Nicola Serroni; Stefano Marini; Gabriella Rapini; Alessandro Valchera; Michele Fornaro; Monica Mazza; Felice Iasevoli; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Case Rep Psychiatry       Date:  2013-05-16

6.  Urethral stricture secondary to self-instrumentation due to delusional parasitosis: a case report.

Authors:  Muhammad Fahmi Ismail; Eugene M Cassidy
Journal:  J Med Case Rep       Date:  2015-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.